Common eye-health nutrient zeaxanthin strengthens T cells and boosts immunotherapy effectiveness in cancer

Common eye-health nutrient zeaxanthin strengthens T cells and boosts immunotherapy effectiveness in cancer

Zeaxanthin is a carotenoid (pigment) found in yellow vegetables like corn and kale and commonly taken as an eye health supplement. A new study found that zeaxanthin also has potent effects on immune cells — specifically, it strengthens T cell function and enhances the effectiveness of cancer immunotherapy.

Researchers discovered that zeaxanthin bolsters T cells, the immune cells most critical to cancer immunotherapy response. In preclinical models, it synergized with immunotherapy to improve anti-cancer outcomes. Because zeaxanthin is already in dietary supplements, is generally considered safe, and is accessible, it has appeal as a low-cost add-on to cancer treatment.

Human clinical trials are described as the next step, suggesting the research is currently at a preclinical stage.

Key Findings

• Zeaxanthin strengthens T cell function relevant to anti-cancer immunity
• Zeaxanthin enhanced the impact of immunotherapy in preclinical cancer models
• The nutrient is found in common vegetables and widely available in supplements
• Safety profile supports feasibility as a clinical trial intervention
• Human clinical trials planned as next step

Implications

If confirmed in human trials, zeaxanthin supplementation could be a low-cost, accessible adjunct to cancer immunotherapy. Its established safety profile and commercial availability would accelerate clinical translation if early trials show benefit.

Caveats

Based on brief news summary; preclinical only (no human data). Details of cancer models and immunotherapy combinations used are not available. Supplement industry claims about zeaxanthin are common; rigorous clinical trial data are needed before clinical recommendations. Summary based on abstract only.

Source: ScienceDaily Cancer — 2026-04-10